BUZZ-<a href="https://laohu8.com/S/COYA">Coya Therapeutics</a> plunges after upsized $20 million share sale** Drug developer Coya Therapeutics' COYA.O shares slide 14% to $6.01 premarket
** COYA announces pricing of upsized $20 million stock offering
** Company sells 3.6 million shares at $5.50 apiece, a 21% discount to stock's last close
** Lucid Capital Markets is sole book-running manager for public offering
** COYA had 16.7 million outstanding shares as of June 30, according to offering prospectus
** Proceeds from the offering will be used for funding its clinical development plan and other purposes
** As of last close, COYA shares up 21.8% YTD
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.